Syn-Coll
SkincareAlso known as: Palmitoyl Tripeptide-5, Pal-Lys-Val-Lys, DSM Collagen Stimulator
Emerging ResearchWhat is Syn-Coll?
A palmitoylated tripeptide developed by DSM (now dsm-firmenich) under the trademark Syn-Coll. Designed to stimulate collagen synthesis via the TGF-β signaling pathway, offering a mechanistic complement to Matrixyl-type peptides that work through extracellular matrix fragment mimicry.
How it works
Pal-Lys-Val-Lys mimics the collagen-stimulating activity of TGF-β1 by binding to the same receptor domain, activating downstream SMAD signaling and upregulating Type I collagen synthesis in dermal fibroblasts. The palmitic acid chain improves skin penetration. Different mechanism from Matrixyl (Pal-KTTKS), which mimics ECM fragments to trigger a wound-repair response — making Syn-Coll a potential complement in formulations targeting multiple collagen pathways.
What marketers claim
- ▸superior to retinol for collagen production
- ▸fills deep wrinkles in days
- ▸replaces TGF-β therapy
What evidence supports
- ✓in vitro: Pal-Lys-Val-Lys significantly increases Type I collagen expression in human fibroblast cultures
- ✓manufacturer-sponsored in vivo study: improved skin firmness and wrinkle depth reduction after 84 days at 3% concentration
- ✓mechanism via TGF-β1 pathway is pharmacologically plausible and supported by cell culture data
Research evidence
Key studies on Syn-Coll, summarized in plain language. This is not an exhaustive list — it highlights the most relevant findings.
Palmitoyl tripeptide-5 stimulates collagen I via TGF-β pathway
Finding: Pal-Lys-Val-Lys at 1 ppm significantly upregulated Type I procollagen mRNA and protein in human fibroblasts; effect blocked by a TGF-β receptor antagonist confirming pathway specificity.
Limitation: In vitro, manufacturer-sponsored, penetration barriers in intact skin not accounted for.
Best for
What to expect
Realistic timeline based on available research. Individual results vary.
Week 1–4
No visible change; collagen synthesis increases in fibroblasts but remodeling takes time.
Week 8–12
Manufacturer data shows measurable improvements in skin firmness and wrinkle depth at 84 days.
Month 4+
Continued collagen accumulation; benefits are gradual and cumulative.
Safety notes & concerns
Full safety guide →- ⚠clinical evidence primarily manufacturer-sponsored (DSM) with limited independent trials
- ⚠effective concentration in finished products rarely disclosed
- ⚠collagen stimulation benefits require 8–12 weeks minimum — as with all signal peptides
- ⚠TGF-β pathway activation has theoretical concerns with long-term overuse in some contexts
Pairs well with
Use caution with
Frequently asked questions
Is Syn-Coll better than Matrixyl?
They work through different pathways — Matrixyl mimics ECM fragments for wound-repair collagen synthesis; Syn-Coll directly activates TGF-β signaling in fibroblasts. Neither has clearly superior evidence in head-to-head trials. Many formulators combine them for a multi-pathway approach.
Related skincare peptides
fine lines, aging skin, anti-aging prevention
expression lines, forehead wrinkles, crow's feet
mature skin, anti-aging prevention, sensitive skin that cannot tolerate retinol
expression lines, forehead wrinkles, those seeking a step up from Argireline
Take the Peptide Quiz
Get personalized recommendations
Stack Builder
Build a routine with Syn-Coll
Last updated: 2026-06-10
Medical Disclaimer
The information on this site is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before starting any new supplement, peptide, or treatment protocol.